Skip to main content

Table 1 Demographic Characteristics of Participants

From: Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy

Variables

Mean ± SD /N(%)

Sex

 Female

11 (2.3%)

 Male

463 (97.7%)

Age, years

34.0 ± 10.1

 18–29

193 (40.7%)

 30–39

168 (35.4%)

 40–49

67 (14.1%)

  ≥ 50

46 (9.7%)

Marital status

 Married/common law marriage

107 (22.6%)

 Single/divorced/widowed

367 (77.4%)

Years of Education

  ≤ 9 years

88 (18.6%)

 10–12 years

75 (15.8%)

  ≥ 13 years

311 (65.6%)

Route of HIV infection

 Homosexual transmission

427 (90.1%)

 Heterosexual transmission

26 (5.5%)

 Intravenous drug use

0 (0%)

 Others

21 (4.4%)

BMI, kg/m2

22.3 ± 3.32

  < 18.5

47 (9.9%)

 18.5–23.9

304 (64.1%)

 24–27.9

94 (19.8%)

  ≥ 28

29 (6.1%)

CD4+ cells/mm3

340.7 ± 241.2

  ≤ 199

119 (25.1%)

 200–349

146 (30.8%)

 350–499

124 (26.2%)

  ≥ 500

85 (17.9%)

Viral load, copies/ml

  < 100,000

382 (80.6%)

  ≥ 100,000

92 (19.4%)

Hepatitis B status

 Positive

31 (6.5%)

 Negative

443 (93.5%)

Hepatitis C status

 Positive

5 (1.1%)

 Negative

469 (98.9%)

Tuberculosis

 Yes

4 (0.8%)

 No

470 (99.2%)

Syphilis

 Yes

149 (31.4%)

 No

325 (68.6%)

WHO Clinical Stage

 I + II

433 (91.4%)

 III + IV

41 (8.6%)